TSHA
Taysha Gene Therapies Inc.
$5.16
+$0.11(+2.08%)
58
Overall
60
Value
72
Tech
44
Quality
Market Cap
$1.29B
Volume
4.79M
52W Range
$1.05 - $5.40
Target Price
$9.50
Key Metrics Overview
| Market Cap | $1.29B | P/E Ratio | N/A |
| 52W High | $5.40 | 52W Low | $1.05 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 57.4% | 52W Position | 94.4% |
| Overall Score | 58 | Value Score | 60 |
| Quality Score | 44 | Technical Score | 72 |
Growth Analysis
| EPS Current Est | $-0.35 | EPS Next Est | $-0.39 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $5.16 | +2.1% | 4.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW